PhagePro, Inc. is an early-stage biotechnology therapeutics company based in Boston, MA. They specialize in developing innovative bacteriophage-based products that target and eliminate bacteria, with the aim of preventing bacterial infections and promoting the well-being of vulnerable communities worldwide.
Spun out of the renowned Camilli Lab at Tufts University School of Medicine, PhagePro harnesses the power of bacteriophages, which are viruses that specifically attack bacteria. Through their discovery-driven approach, they strive to create a healthier world by providing effective solutions to combat bacterial infections and improve the lives of those in need.
Generated from the website